Meridian Wealth Advisors’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Meridian Wealth Advisors’s Portfolio TFFP Stock Details TFFP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-463	Closed	-$4.05K	–	184
2023 Q3	$4.05K	Hold	463	–	–	﹤0.01%	178
2023 Q2	$5.44K	Hold	463	–	–	﹤0.01%	183
2023 Q1	$7.93K	Buy	+463	New	+$10K	﹤0.01%	188
2022 Q4	–	Sell	-460	Closed	-$47K	–	200
2022 Q3	$47K	Hold	460	–	–	0.01%	185
2022 Q2	$65K	Hold	460	–	–	0.02%	194
2022 Q1	$73K	Hold	460	–	–	0.02%	210
2021 Q4	$102K	Hold	460	–	–	0.02%	200
2021 Q3	$89K	Hold	460	–	–	0.02%	194
2021 Q2	$111K	Hold	460	–	–	0.03%	193
2021 Q1	$156K	Hold	460	–	–	0.05%	181
2020 Q4	$165K	Hold	460	–	–	0.06%	171
2020 Q3	$212K	Buy	+460	New	+$130K	0.09%	152

Other funds holding TFFP

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Meridian Wealth Advisors's TFFP Position: Q4 2023 in Review

Meridian Wealth Advisors sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2023, closing a stake of 463 shares — an estimated $4.05K sold.

Meridian Wealth Advisors first reported a position in TFFP in Q3 2020 and held it in 12 quarters. The position peaked at $212K in Q3 2020. 23 funds tracked by Wall St. Rank hold TFFP as of Q4 2023.

Meridian Wealth Advisors reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Meridian Wealth Advisors sold 463 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $4.05K.
Meridian Wealth Advisors first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 12 quarters.
Meridian Wealth Advisors's TFF Pharmaceuticals, Inc. Common Stock position peaked at $212K in Q3 2020.
23 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Meridian Wealth Advisors's 13F filing for Q4 2023, filed 6 Feb 2024.